Back to top
Link to our global home page
Print |

Our Credentials

Our credentials are demonstrated by our clients, our leadership in the management and delivery of knowledge in professional services, and our commitment over many years to the health sciences sector.

Recent transactions include:

  • Reporting accountants to several companies in respect of their IPOs on AIM, London Stock Exchange and NASDAQ
  • Acquisition support to Astex Therapeutics on their acquisition of Metagen
  • IFRS and S.404 support to pre IPO companies and those already listed
  • Tax planning advice for companies seeking IPOs including share option planning

Health Sciences
Our leadership in professional advice to health sciences companies in the US and Europe is widely acknowledged in the industry. For example, our annual US, European and Global reports on the industry are widely cited in the media and professional press, and are the platform for our frequent presentations at international conferences and meetings with industry executives. They comment extensively on current trends and developments in the industry and are a valuable source of reference.

Thought Leadership
We demonstrate our commitment and investment in the industry through our original insight and thought leadership. We also support many industry events including:

  • BIO;
  • ERBI; and
  • Sponsorship of the 5th Annual BioIndustry Association CEO Dinner
Knowledge Beyond Borders – EY’s 20th Annual global biotechnology report
Photo - Beyond Borders 2006 sm Now recognised as the industry bible, Ernst & Young’s global biotechnology report, Beyond Borders, provides an overview of the latest developments in the Global biotechnology sector. Our report demonstrates that on the cusp of its 30th birthday, the biotech industry is maturing rapidly, with solid financial performance and a substantial track record of bringing new products to market.

Back to the top


Our credentials in the global Health Sciences sector

The global market
The Health Sciences industry is widely acknowledged as one of the leading industries in the future global economy.

Ernst & Young is the leader among professional services firms in delivering the value – ideas, solutions and results – that clients care about. We have the industry experience and technical skills to provide ideas and solutions that are tailored to our clients’ needs and deliver results that they can measure.

A lead advisor in Health Service
Ernst & Young is the leader in servicing the Health Sciences industry. We dominate in services to the Health Science industry because we understand the industry and its environment, as well as the challenges faced by businesses. More importantly we know how to help our clients meet those challenges.

The leading business adviser to the Health Sciences industry:

  • advising 1/3 of companies globally
  • having a global network of Health Sciences specialists in 17 European countries
  • having the UK’s largest dedicated Health Sciences team including Life Sciences PhDs, experts on UK and US reporting and industry analysts
  • producing the authoritative Global Biotechnology Report, this year entitled Beyond Borders
  • hosting the annual Biotechnology Industry Association CEO Forum.

Back to the top

Biotechnology


US Biotechnology Companies

E&Y:55 PWC:33 KPMG:25 D&T:23
The Ames Research Group’s Leading Database
Number of US Biotechnology Companies Audited

Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any services to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.